Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Adult Hodgkin lymphoma AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Prognosis
124 results:

  • 1. Predictive and prognostic molecular biomarkers in lymphomas.
    Iorgulescu JB; Medeiros LJ; Patel KP
    Pathology; 2024 Mar; 56(2):239-258. PubMed ID: 38216400
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Indolent T-lymphoblastic proliferation involving hepatocellular carcinoma-presentation in novel settings and comprehensive review of literature.
    Ghezavati A; Liang CA; Mais D; Nazarullah A
    J Hematop; 2023 Sep; 16(3):167-175. PubMed ID: 38175402
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Broadening the horizon: potential applications of CAR-T cells beyond current indications.
    Karsten H; Matrisch L; Cichutek S; Fiedler W; Alsdorf W; Block A
    Front Immunol; 2023; 14():1285406. PubMed ID: 38090582
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Bortezomib Is Effective in the Treatment of T Lymphoblastic Leukaemia by Inducing DNA Damage, WEE1 Downregulation, and Mitotic Catastrophe.
    Din RU; Jiao A; Qiu Y; Mohan AAM; Yuen KC; Wong HT; Wan TM; Wong PO; Sin CF
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834095
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma.
    Yang X; Luo C; Qian J; Huang X; Zhang J; Wang J; Luo C; Qin X; Li B; Chen J
    Front Immunol; 2023; 14():1219872. PubMed ID: 37736096
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell Therapies.
    Schorr C; Forindez J; Espinoza-Gutarra M; Mehta R; Grover N; Perna F
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176053
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma].
    Dourthe ME; Simonin M; Rigaud C; Haouy S; Montravers F; Ducou Le Pointe H; Garnier N; Minard-Colin V; Jo Molina T; Boudjemaa S; Leblanc T; Landman-Parker J
    Bull Cancer; 2023 Sep; 110(9):968-977. PubMed ID: 37062647
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic value of cross-lineage expression of the myeloid-associated antigens CD13 and CD33 in adult B-lymphoblastic leukemia: A large real-world study of 1005 patients.
    Liao H; Lai H; Chen J; Shuai X; Zhang X; Yang Y; Lyu M; Zheng Q
    Cancer Med; 2023 Apr; 12(8):9615-9626. PubMed ID: 36951610
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies.
    Topp M; Dlugosz-Danecka M; Skotnicki AB; Salogub G; Viardot A; Klein AK; Hess G; Michel CS; Grosicki S; Gural A; Schwarz SE; Pietzko K; Gärtner U; Strassz A; Alland L; Mayer J
    Trials; 2023 Jan; 24(1):4. PubMed ID: 36597128
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Analysis of 42 cases of childhood superior vena cava syndrome associated with mediastinal malignancy].
    Yang QS; Han YL; Cai JY; Gu S; Bai J; Ren H; Xu M; Zhang J; Zhang AA; Su M; Pan C; Wang Y; Tang JY; Gao YJ
    Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1026-1030. PubMed ID: 36207849
    [No Abstract]    [Full Text] [Related]  

  • 11. Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).
    Whitlock JA; Malvar J; Dalla-Pozza L; Goldberg JM; Silverman LB; Ziegler DS; Attarbaschi A; Brown PA; Gardner RA; Gaynon PS; Hutchinson R; Huynh VT; Jeha S; Marcus L; Messinger Y; Schultz KR; Cassar J; Locatelli F; Zwaan CM; Wood BL; Sposto R; Gore L
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29901. PubMed ID: 35989458
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Unity brings strength: Combination of CAR-T cell therapy and HSCT.
    Huang R; Wang X; Zhang X
    Cancer Lett; 2022 Nov; 549():215721. PubMed ID: 35537573
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Isatuximab monotherapy in patients with refractory T-acute lymphoblastic leukemia or T-lymphoblastic lymphoma: Phase 2 study.
    Boissel N; Chevallier P; Doronin V; Griskevicius L; Maschan A; McCloskey J; Rambaldi A; Rossi G; Sokolov A; Wartiovaara-Kautto U; Oprea C; Abbadessa G; Gosselin A; Macé S; Thomas X
    Cancer Med; 2022 Mar; 11(5):1292-1298. PubMed ID: 35106962
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Distinct clinical characteristics of DUX4- and PAX5-altered childhood B-lymphoblastic leukemia.
    Li Z; Lee SHR; Chin WHN; Lu Y; Jiang N; Lim EH; Coustan-Smith E; Chiew KH; Oh BLZ; Koh GS; Chen Z; Kham SKY; Quah TC; Lin HP; Tan AM; Ariffin H; Yang JJ; Yeoh AE
    Blood Adv; 2021 Dec; 5(23):5226-5238. PubMed ID: 34547766
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical Characteristics of Hemophagocytic Lymphohistiocytosis Associated with Non-hodgkin B-Cell lymphoma: A Multicenter Retrospective Study.
    Li B; Guo J; Li T; Gu J; Zeng C; Xiao M; Zhang W; Li Q; Zhou J; Zhou X
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e198-e205. PubMed ID: 33303420
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Exploring the Dilemma of Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy: To Transplant or Not?
    Bouziana S; Bouzianas D
    Biol Blood Marrow Transplant; 2020 Aug; 26(8):e183-e191. PubMed ID: 32304874
    [TBL] [Abstract] [Full Text] [Related]  

  • 17.
    Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.
    Krysiak K; Gomez F; White BS; Matlock M; Miller CA; Trani L; Fronick CC; Fulton RS; Kreisel F; Cashen AF; Carson KR; Berrien-Elliott MM; Bartlett NL; Griffith M; Griffith OL; Fehniger TA
    Blood; 2017 Jan; 129(4):473-483. PubMed ID: 28064239
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Outcome of children and adolescents with lymphoblastic lymphoma.
    Oliveira MC; Sampaio KC; Oliveira AC; Santos AD; Castro LP; Viana MB
    Rev Assoc Med Bras (1992); 2016; 62(1):59-64. PubMed ID: 27008495
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-hodgkin's lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract] [Full Text] [Related]  


    of 7.